Scientists Warn Popular 'Mother of All Antioxidants' Supplement Can Cause Harm

Friday, June 19th, 2026 - A widely marketed dietary supplement often called the "mother of all antioxidants" may pose health risks, scientists are warning, according to a report published by Inc. The supplement, which has gained popularity among consumers seeking anti-aging and wellness benefits, is under renewed scrutiny as researchers highlight potential harms that contradict its marketed safety profile.

Safety Concerns Emerge

The Inc. report, citing scientific experts, indicates that the supplement—marketed as a powerful antioxidant—can cause adverse effects when taken in high doses or without medical supervision. Researchers caution that the compound's potent biological activity, while beneficial in controlled contexts, may lead to unintended consequences including oxidative stress under certain conditions, contradicting the supplement's core marketing claims.

Clinical Context

The warning adds to a growing body of evidence that dietary supplements marketed as "antioxidants" require careful dosing and medical oversight. Unlike FDA-approved peptide therapeutics, which undergo rigorous clinical testing for safety and efficacy, many antioxidant supplements enter the market through less stringent regulatory pathways, leaving consumers vulnerable to unverified health claims.

Regulatory Implications

The report underscores ongoing concerns about the regulatory gap between FDA-approved peptide drugs and unregulated dietary supplements. While the FDA maintains oversight of drug safety through clinical trials and post-market surveillance, supplements marketed as "natural" or "antioxidant" often bypass these requirements, creating potential risks for consumers who may assume they are harmless.

Related Reading

• For ongoing coverage of FDA actions on unapproved peptide products, see Medriva's FDA Warning Letters Tracker
• For context on the regulatory distinction between approved drugs and supplements, see 503A vs 503B Compounding Explained
• For Medriva's clinical review methodology, see Clinical Review Methodology